138 related articles for article (PubMed ID: 16234120)
1. [Determination of plasma and sputum substance P content in patients with chronic obstructive pulmonary disease or asthma].
Zhang D; Luo XR; Ye XQ; Dong XF
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1314-5. PubMed ID: 16234120
[TBL] [Abstract][Full Text] [Related]
2. [Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
Tian L; Cai L; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):138-40. PubMed ID: 11778483
[TBL] [Abstract][Full Text] [Related]
3. [ICAM-1 and HLA-DR expression in bronchial epithelial cells from patients with chronic obstructive pulmonary disease].
Qu Q; Zhao M; Gu G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):411-4. PubMed ID: 11326880
[TBL] [Abstract][Full Text] [Related]
4. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].
Cheng Z; Kang Y; Wu QG; Dai LL; Song YN; Xia J; Si JM; Chen CY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):2981-4. PubMed ID: 22333024
[TBL] [Abstract][Full Text] [Related]
5. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
6. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
7. [The levels and clinical implications of induced sputum interleukin-17 in chronic obstructive pulmonary disease and asthma].
Shen F; Zhao MW; He B; Wang YZ; Yao WZ
Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):888-90. PubMed ID: 15730730
[TBL] [Abstract][Full Text] [Related]
8. [Substance P in the sputum of patients with chronic obstructive pulmonary disease and occupational exposure to respiratory irritants].
Boschetto P; Quintavalle S; Mazzetti L; Miotto D; Bononi I; Mapp CE; De Rosa E
G Ital Med Lav Ergon; 2003; 25 Suppl(3):129-30. PubMed ID: 14979114
[TBL] [Abstract][Full Text] [Related]
9. [Detection and significance of interleukin-8,6, tumor necrosis factor-alpha in sputa from patients with chronic obstructive pulmonary disease].
Wang S; Xu F; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Aug; 23(8):465-7. PubMed ID: 11778258
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
11. [Tumor necrosis factor in sputa of patients with bronchial asthma on exacerbation].
Taki F; Kondoh Y; Matsumoto K; Takagi K; Satake T; Taniguchi H; Matsuzaki M
Arerugi; 1991 Jun; 40(6):643-6. PubMed ID: 1892447
[TBL] [Abstract][Full Text] [Related]
12. Analysis of plasma-protein leakage and local secretion in sputum from patients with asthma and chronic obstructive pulmonary disease.
Schoonbrood DF; Lutter R; Habets FJ; Roos CM; Jansen HM; Out TA
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1519-27. PubMed ID: 7952610
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
15. Serum and sputum neurotrophin levels in chronic persistent cough.
Chaudhuri R; McMahon AD; McSharry CP; Macleod KJ; Fraser I; Livingston E; Thomson NC
Clin Exp Allergy; 2005 Jul; 35(7):949-53. PubMed ID: 16008683
[TBL] [Abstract][Full Text] [Related]
16. [Procollagen type 111 peptide levels in patients with bronchial asthma and COPD].
Kolevska T; Jagić V; Cvoriscec B; Palecek I; Tudman Z; Stipić-Marković A
Plucne Bolesti; 1991; 43(1-2):59-61. PubMed ID: 1766989
[TBL] [Abstract][Full Text] [Related]
17. Smoking affects eotaxin levels in asthma patients.
Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of induced sputum test in monitoring airway inflammation in asthma].
Zhang HB; Lin YG; Zhao XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):432-4. PubMed ID: 12905856
[TBL] [Abstract][Full Text] [Related]
19. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene E(4) in urine in patients with asthma and COPD--the effect of smoking habit.
Gaki E; Papatheodorou G; Ischaki E; Grammenou V; Papa I; Loukides S
Respir Med; 2007 Apr; 101(4):826-32. PubMed ID: 16965907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
